Business
Why the Genetic Signatures (ASX:GSS) share price is edging higher
The Genetic Signatures Ltd (ASX: GSS) share price is edging higher today. This comes after the company announced that it received CE-IVD registration for its 3base EasyScreen sexually transmitted infection (STI) Genital Pathogen Detection Kit.
CE-IVD refers to an approved CE Marking from the European Union for an in vitro diagnostic (IVD) device. This allows the product to be commercially sold within Europe.
What’s driving the Genetic Signatures share price higher
The Genetic Signatures share price is back positive territory as investors jump on the company’s latest news. Originally, the company’s shares were sliding lower on the back of overall weak market sentiment.
According to its release, Genetic Signatures advised its…
-
Noosa News13 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
Noosa News23 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane
-
General9 hours agoChoosing an online exercise program can be confusing. Here’s what to look out for
-
Noosa News13 hours agoNowhere is growing like this corner of Queensland. It’s changing the political game